Articles On Telix Pharmaceuticals (ASX:TLX)

It's a great day on the S&P/ASX 200 Index (ASX: XJO) today. At the time of writing, the benchmark Aussie index is up 1.6% at 7,939.1 points. ASX 200 uranium stock Paladin Energy Ltd (ASX: PDN) is leading the charge, with shares up 21.6%...

Highlights  ASX jumps nearly 2% on Wall Street rally and US tariff rollback signals  Resource and tech stocks post strong gains amid easing trade concerns  Telix, Paladin shine with major updates; Cettire tumbles on weak demand  A...

Telix’s quarterly sales reflect first revenue from the company’s recent purchase of a US nuclear medicine manufacturer Island Pharma hopes to lift the kimono on its dengue fever trial next month Race Oncology kicks off its cancer-busting,...

Highlights  ASX opens with a sharp gain following Wall Street momentum  Paladin Energy leads with record quarterly output  Gold stocks retreat as prices peak above $US3500/oz  Australian shares climbed sharply in early trade, lift...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are catching the eye on Wednesday morning. At the time of writing, the ASX 200 biotech company's shares are up 15% to $28.95. Telix shares rocket on Q1 update Investors have been buying the compan...

Highlights  ASX 200 futures rise over 1.2% following a broad-based US market rebound  Global sentiment boosted by signs of progress in trade negotiations with Japan and India  Gold stocks ease, while growth-oriented sectors and tech E...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) started the shortened week with a small decline. The benchmark index edged slightly lower to 7,816.7 points. Will the market be able to bounce back from this on Wednesday? Here are five thi...

Highlights: Nextdc operates data centres across the Asia-Pacific, supporting cloud and AI infrastructure Telix Pharmaceuticals develops radiopharmaceuticals for oncology imaging and therapy Both companies continue to expand...

If you are lucky enough to have $10,000 to invest and also have a penchant for ASX growth shares, then read on! That's because listed below are three fantastic shares that analysts are tipping to grow strongly in the coming years. Here's wh...

Highlights James Hardie Industries continues to benefit from rising demand for fibre cement in North America ResMed maintains market presence with its respiratory care product portfolio and recurring revenue base Telix Pharm...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 /PRNewswire/ — Telix Pharma...

If you are on the lookout for some investment ideas, then it could be worth checking out what analysts saying. Listed below are five ASX 200 stocks that leading brokers currently rate as buy. Here's what they are recommending to clients: J...

With markets still struggling for direction, now might be the ideal time for long-term investors to focus on quality — and there's no shortage of it on the ASX. Analysts at Bell Potter have recently named a select group of ASX shares they...

On Friday, the S&P/ASX 200 Index (ASX: XJO) ended the week in the red. The benchmark index dropped 0.8% to 7,646.5 points. Will the market be able to bounce back from this on Monday? Here are five things to watch: ASX 200 expected to...

Donald Trump’s latest tariff bombshell has shaken global markets and it’s raising serious questions. Was this chaos just bad policy… or something more calculated? Listen to the HotCopper podcast for in-depth discussions and insights on a...

Highlights: Financial sector unchanged by midday as broader market trends lower Regal Partners reports a decline in funds under management over the quarter Healthcare sector leads losses amid tariff concerns and industry dev...

Highlights: ASX lifts sharply with all sectors closing higher, rebounding from prior session declines Nikkei records strong movement as markets respond to tariff rhetoric Resource and tech firms lead gains, while a few small...

ASX rallies 2.27% after shedding 4% yesterday Nikkei225 soars almost 6%, recovering from Monday’s losses Trade war threatens to escalate as China calls tariff escalations ‘a mistake’.   The ASX posted a strong gain to rise 2.27% today, re...

It was a stunning recovery day for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Tuesday. After the carnage that kicked off the trading week yesterday, investors were clearly in the mo...

Highlights: ASX index experiences its heaviest single-day loss since the early pandemic period Commodity prices, including gold and copper, decline sharply as global markets reel Buyout proposal drives significant gains for...

Companies including Cochlear and Telix affirm that tariffs are likely to be a ‘Y2K’ non-event Bell Potter says Trajan shares are worth double their current price Plucky Biotron lives another day after passing the hat   On the evening of D...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Tariff rumours whipsawed the S&P500 over an 8.5% range from trough-to-peak over...

Highlights: Lynas Rare Earths and Nyrada advanced while most sectors declined Abacus Storage King surged following a major acquisition proposal Woodside Energy and Kelsian Group posted declines despite business developments...

The ASX200 closed down 4.2% at 7,343 points in a $97B wipeout for the market. The Energy sector was decimated, down 7%, followed by Financials, down 5%, and Materials and Discretionary – both down 4.8%. In the Green Lynas Rare News...

ASX tanks 4pc, worst drop since may 2020 Gold, copper, Bitcoin hammered in global rout Abacus Storage King bursts up after receiving buyout proposal    The ASX has taken a big hit on Monday, dropping by 4% as it marked the worst one-day l...

The ASX 200 index is crashing on Monday following an equally brutal selloff on Wall Street on Friday. While it certainly is a tough time for ASX investors, it could also be one of the best buying opportunities we have had in years and an id...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, April 7, 2025 /PRNewswire/ — Telix Pharmac...

The recent share market selloff has rattled investor confidence — but for those thinking long term, it could be a gift in disguise. When share prices drop across the board, it often has less to do with company fundamentals and more to do...

If you are looking for ASX 200 stocks to buy in April after recent weakness, then it could be worth listening to what analysts at Bell Potter are saying. That's because the broker has just revealed its favoured picks for the month ahead o...

Donald Trump exempts “pharmaceuticals” from his tariff blitz ASX device makers mull their US manufacturing plans as Ansell shares plunge Race and Imugene progress their early-stage oncology trials   Liberation Day has spared the pharmaceu...

If you're looking to invest in the next generation of ASX success stories, sometimes you need to look beyond the usual household names. While the big end of town offers stability, it's often the mid-caps and emerging leaders that deliver th...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, April 2, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited...

Some investors contend Clinuvel’s mountain of $200 million of cash is excessive and amounts to a ‘lazy’ balance sheet The company argues the cash buffer protects it against unexpected adversities and – in any event – every cent will be nee...

I think it is fair to say that 2025 hasn't exactly started the way most investors were hoping. Trade tensions, market jitters, and a sharp selloff in growth and tech stocks have sent many ASX shares tumbling well off their highs. And while...

Despite a late upturn, the ASX 200 closed 0.38% in the red on Thursday Blame factor 1: Trump and his 25% US auto import tariffs, set to come into play early April Blame factor 2: A Wall Street tech rout, which Trump had a hand in, too   ...

A cabal of ASX drug developers has defied the US gloom The healthcare jury’s out on new FDA head Dr Marty Makary Emvision’s Emu trial takes flight Amid the downbeat narrative about US healthcare policy and cuts to funding agencies, a ‘Mag...

The team at Bell Potter has been busy running the rule over the healthcare sector and has picked out a number of stocks that it believes are attractive options right now. Let's see what the broker is recommending investors buy now: Clinuve...

Highlights: FDA approval for a new imaging agent by Telix Pharmaceuticals influences discussions across market sectors. Resource industry undergoes shifts with notable divestments and operational challenges due to climatic condit...

The ASX has been trading flat at around 7,922 points on Friday. Staples has been the best-performing sector, up 3%, followed by Industrials and Utilities, both up 0.5%. Health Care has been the worst-performing, down 0.6%, followed by...

Highlights:  US Markets Retreat: S&P 500 erased early gains, closing slightly lower amid a lack of clear market direction.  Central Banks in Focus: The Bank of England, Sweden, and Taiwan maintained interest rates, while Switzerlan...

S&P/ASX 200 Index (ASX: XJO) healthcare stock Telix Pharmaceuticals Ltd (ASX: TLX) is marching higher today. Shares in the diagnostic and therapeutic product developer closed yesterday trading for $27.80. In morning trade on Friday, sh...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have slipped by around 11% from their former highs of $31 apiece since February. This isn't a Telix-only issue. The S&P/ASX 200 Index (ASX: XJO) is also down 5% this past month. This comes...

It was a return to red ink for the S&P/ASX 200 Index (ASX: XJO) this Wednesday, as investors lost the steam that had been powering a recovery over the past few trading days. By the time trading w...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are pointing to another down day as traders take risk off the table ahea...

Despite the current political upheaval, the US health sector remains the first port of call for most biotechs FDA approvals have sparked one-day share surges of as much as 500% Several ASX companies await do-or-die FDA approvals Despite r...

Telix Pharmaceuticals’ Brazilian win marks its first foray into the South American market Orthocell gains approval to sell its dental guided bone regeneration product in Singapore Sigma Healthcare: great prospects, a pity about the valuati...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ — Teli...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin A fall in airfares assisted a lower-than-expected February US Core CPI print (pre-ta...

S&P/ASX 200 Index (ASX: XJO) share Telix Pharmaceuticals Ltd (ASX: TLX) is slipping today. Shares in the diagnostic and therapeutic product developer closed yesterday trading for $26.61. In morning trade on Wednesday, shares are swappi...

Healthcare analysts say Neuren shares should be worth more than double what they are Biotech sector retreats in February, despite some record results Dimerix pockets $3.2 million payment from Japanese partner   Some healthcare analysts be...